BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,055 filers reported holding BAXTER INTL INC in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $217,000 | -10.3% | 2,795 | 0.0% | 0.12% | -11.8% |
Q4 2021 | $242,000 | +9.5% | 2,795 | +1.8% | 0.14% | +9.7% |
Q3 2021 | $221,000 | +8.9% | 2,745 | 0.0% | 0.12% | +10.7% |
Q2 2021 | $203,000 | -14.0% | 2,745 | -3.5% | 0.11% | -18.2% |
Q1 2021 | $236,000 | +6.3% | 2,845 | 0.0% | 0.14% | -3.5% |
Q4 2020 | $222,000 | -54.9% | 2,845 | -53.7% | 0.14% | -22.4% |
Q3 2020 | $492,000 | +78.9% | 6,147 | +92.3% | 0.18% | -13.3% |
Q2 2020 | $275,000 | +6.2% | 3,196 | 0.0% | 0.21% | -16.9% |
Q1 2020 | $259,000 | -3.0% | 3,196 | 0.0% | 0.25% | +38.0% |
Q4 2019 | $267,000 | -4.6% | 3,196 | 0.0% | 0.18% | -10.2% |
Q3 2019 | $280,000 | +6.9% | 3,196 | 0.0% | 0.20% | +7.3% |
Q2 2019 | $262,000 | -0.8% | 3,196 | -1.5% | 0.19% | +0.5% |
Q1 2019 | $264,000 | +1.5% | 3,246 | -17.7% | 0.19% | -6.4% |
Q4 2018 | $260,000 | -16.7% | 3,946 | -2.5% | 0.20% | -1.9% |
Q3 2018 | $312,000 | +4.3% | 4,046 | 0.0% | 0.21% | -3.3% |
Q2 2018 | $299,000 | +13.7% | 4,046 | 0.0% | 0.21% | +8.6% |
Q1 2018 | $263,000 | +0.4% | 4,046 | 0.0% | 0.20% | +10.1% |
Q4 2017 | $262,000 | +3.1% | 4,046 | 0.0% | 0.18% | +0.6% |
Q3 2017 | $254,000 | +3.7% | 4,046 | 0.0% | 0.18% | 0.0% |
Q2 2017 | $245,000 | +16.7% | 4,046 | 0.0% | 0.18% | +14.8% |
Q1 2017 | $210,000 | -99.9% | 4,046 | -3.1% | 0.16% | +32.5% |
Q1 2016 | $171,550,000 | +7.7% | 4,176 | 0.0% | 0.12% | +9.3% |
Q4 2015 | $159,314,000 | +16.1% | 4,176 | 0.0% | 0.11% | +5.9% |
Q3 2015 | $137,182,000 | -55.7% | 4,176 | -5.6% | 0.10% | -53.0% |
Q2 2015 | $309,510,000 | +2.1% | 4,426 | 0.0% | 0.22% | +2.4% |
Q1 2015 | $303,181,000 | -6.5% | 4,426 | 0.0% | 0.21% | -6.2% |
Q4 2014 | $324,382,000 | +2.1% | 4,426 | 0.0% | 0.22% | -1.8% |
Q3 2014 | $317,654,000 | -12.3% | 4,426 | -15.3% | 0.23% | -30.9% |
Q2 2013 | $362,005,000 | – | 5,226 | – | 0.33% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |